Luye Pharma Group Ltd. LYPHF
0.27 USD 0.00 0.00%
At close · Oct 30
0.2041 52-week range 0.395
- YTD
- -30.82%
- 1 year
- +0.75%
- Open
- 0.27
- Prev close
- 0.27
- Mkt cap
- 1.08B
- Vol
- 2.50K
- Avg vol
- 0
- EPS
- 0.01
- P/E
- 27.00
More statistics
- Low
- 0.27
- High
- 0.27
- Earnings
- Aug 27, 2026
MAX chart
Chart tools
Chart is warming up
The all-time price history for LYPHF has not been loaded yet. Try again in a moment.
Altman Z-Score
1.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 4
- P/B 5
P/E 18.2×
P/S 1.7×
P/B 0.7×
P/FCF 13.6×
EV/EBITDA 7.6×
EV/Sales 2.5×
FCF Yield 7.3%
Gross Margin 66.0%
Operating Margin 19.8%
Net Margin 9.8%
ROE 3.7%
ROIC 3.1%
ROA 1.8%
Revenue 1.4%
Operating Income -5.6%
EPS (diluted) 757.1%
Free Cash Flow 150.7%
Current Ratio 1.5×
Quick Ratio 1.4×
Debt / Equity 0.6×
Net Debt / EBITDA 2.4×
Interest Coverage 1.8×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31